🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic malignancy.

“The brilliant light of our family has dimmed his light for us in this life,” his relatives confirmed. “After a lengthy and courageous struggle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The album premiered at No. 1 on both the R&B charts and the Billboard 200. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal featured the singer, famously stripped down to his waist, performing straight into the camera.

D’Angelo stepped back from the spotlight after putting out Voodoo and openly battled with substance abuse. In 2005, he was involved in a severe vehicle accident that left him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the R&B chart and a award for Best R&B Album.

Again, in his own enigmatic way, D’Angelo had limited public outings in the subsequent period.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was called off, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s well-being in the weeks leading up to his passing, he had apparently been in the hospital for an extended period and in hospice for a fortnight.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are saddened that he can only leave cherished moments with his loved ones, but we are forever thankful for the legacy of extraordinarily moving songs he leaves behind,” his kin expressed.

Pancreatic Cancer: Deadly and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a tiny gland that produces insulin and is vital in digestion, among additional roles. The position and dimensions of the pancreas in the human system make it more difficult to identify malignancy.

Even though this cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of malignancy fatalities.

Almost 70,000 people will be found to have this condition and about 52,000 will die of the disease in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a significant difference on the well-being of people,” said a cancer specialist.

Because this disease rarely causes initial signs, it’s frequently identified only once the condition is late-stage. Although a individual has indicators they are usually vague and may be mistaken for a number of everyday ailments.

“As of yet, there is no effective method to detect pancreatic cancer in the early stages, except for listening to your body and consulting your doctor if there are unfamiliar signs,” said a medical director.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as this malignancy is typically found in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become more common among younger people.

“Pancreatic cancer identified prior to fifty is considered rare, yet alarmingly, doctors are noticing a growing number of younger patients suffering from this condition,” commented a expert.

Genetic Background Impacts Cancer Risk

In the absence of effective detection methods for this malignancy, experts emphasized the importance of knowing your relatives’ health background. Some contributing elements, such as tobacco use and obesity also have an influence in the onset of pancreatic cancer.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are most likely to be diagnosed with inoperable cancer.

“The first step toward lowering one’s chance of pancreatic cancer is assessing individual susceptibility. People should examine their family history, hereditary factors, and health issues, such as diabetes, chronic pancreatitis, or overweight that may increase their vulnerability,” said a specialist.

Hereditary elements are associated with as much as 10% of all this malignancy cases. If someone in your household has had pancreatic cancer, you may want to think about DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find initial alterations in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may have an effect. The most effective action you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreas inflammation, a risk factor for pancreatic cancer, so limiting or abstaining from alcohol may help lower your chance.

Controlling your weight or losing weight may also aid reduce your risk. Individuals with obesity are 20% more likely to get pancreatic cancer. Pancreatic cancer also is more frequent in those with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are developing targeted therapies that already are showing results,” remarked a expert.

For many individuals, however, education about this rare but {dev